Media Update: ERS: Dupixent data reinforce clinically meaningful benefit from pooled analysis of two COPD phase 3 studies

Nitesh sinha September 10, 2024
https://ift.tt/BcI7X3j

ERS: Dupixent data reinforce clinically meaningful benefit from pooled analysis of two COPD phase 3 studies



from Sanofi - Aventis Groupe https://ift.tt/wSdEYHO
via IFTTT
Tags:
Nitesh sinha

Posted by: Nitesh sinha

Post a Comment

0 Comments

Please ,
Do not enter any kind of span link